Lilach Agemy

4.3k total citations · 2 hit papers
27 papers, 3.2k citations indexed

About

Lilach Agemy is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Spectroscopy. According to data from OpenAlex, Lilach Agemy has authored 27 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 9 papers in Radiology, Nuclear Medicine and Imaging and 7 papers in Spectroscopy. Recurrent topics in Lilach Agemy's work include Advanced MRI Techniques and Applications (7 papers), Advanced NMR Techniques and Applications (6 papers) and Nanoplatforms for cancer theranostics (5 papers). Lilach Agemy is often cited by papers focused on Advanced MRI Techniques and Applications (7 papers), Advanced NMR Techniques and Applications (6 papers) and Nanoplatforms for cancer theranostics (5 papers). Lilach Agemy collaborates with scholars based in Israel, United States and Spain. Lilach Agemy's co-authors include Venkata Ramana Kotamraju, Erkki Ruoslahti, Kazuki N. Sugahara, Tambet Teesalu, Priya Karmali, Olivier M. Girard, Robert F. Mattrey, Daniel Greenwald, Douglas Hanahan and Lise Roth and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Clinical Oncology.

In The Last Decade

Lilach Agemy

26 papers receiving 3.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Tissue-Penetrating Delivery of Compounds and Nanoparticles into Tumors

2009 925 citations Kazuki N. Sugahara, Tambet Teesalu et al. Cancer Cell profile →
Coadministration of a Tumor-Penetrating Peptide Enhances the Efficacy of Cancer Drugs

2010 876 citations Kazuki N. Sugahara, Tambet Teesalu et al. Science profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lilach Agemy Israel	16	1.8k	1.2k	1.1k	554	457	27	3.2k
Priya Karmali United States	28	2.8k 1.5×	1.6k 1.3×	1.2k 1.1×	565 1.0×	319 0.7×	50	4.6k
Trevor D. McKee Canada	23	1.3k 0.7×	798 0.7×	1.4k 1.2×	834 1.5×	273 0.6×	54	3.6k
David C. Blakey United Kingdom	25	1.9k 1.0×	773 0.6×	849 0.8×	643 1.2×	475 1.0×	52	3.6k
Miles A. Miller United States	33	1.5k 0.8×	796 0.7×	1.4k 1.3×	1.1k 1.9×	338 0.7×	77	3.9k
Dražen Raucher United States	32	2.1k 1.1×	1.1k 0.9×	831 0.7×	288 0.5×	144 0.3×	72	4.3k
Gerben A. Koning Netherlands	43	2.9k 1.6×	2.5k 2.1×	2.1k 1.8×	548 1.0×	758 1.7×	98	5.5k
Katherine S. Yang United States	24	1.5k 0.8×	407 0.3×	783 0.7×	786 1.4×	314 0.7×	48	2.9k
Mahaveer S. Bhojani United States	23	1.4k 0.8×	483 0.4×	735 0.7×	749 1.4×	264 0.6×	37	2.8k
Christopher G. England United States	31	1.3k 0.7×	527 0.4×	1.2k 1.0×	707 1.3×	762 1.7×	50	3.3k
Oula Peñate Medina Germany	15	961 0.5×	911 0.8×	976 0.9×	320 0.6×	325 0.7×	29	2.5k

Countries citing papers authored by Lilach Agemy

Since Specialization

Citations

This map shows the geographic impact of Lilach Agemy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lilach Agemy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lilach Agemy more than expected).

Fields of papers citing papers by Lilach Agemy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lilach Agemy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lilach Agemy. The network helps show where Lilach Agemy may publish in the future.

Co-authorship network of co-authors of Lilach Agemy

This figure shows the co-authorship network connecting the top 25 collaborators of Lilach Agemy. A scholar is included among the top collaborators of Lilach Agemy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lilach Agemy. Lilach Agemy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sasson, Keren, et al.. (2024). Molecular imaging of tumor metabolism: Insight from pyruvate- and glucose-based deuterium MRI studies. Science Advances. 10(11). eadm8600–eadm8600. 14 indexed citations

Agemy, Lilach, et al.. (2024). Abstract 6644: aPD1 treatment of urothelial cancers is synergistically enhanced by activating anti tumor immunity using vascular targeted photodynamic therapy. Cancer Research. 84(6_Supplement). 6644–6644.

Sasson, Keren, Lilach Agemy, Dana C. Peters, et al.. (2023). High-sensitivity deuterium metabolic MRI differentiates acute pancreatitis from pancreatic cancers in murine models. Scientific Reports. 13(1). 19998–19998. 17 indexed citations

Peters, Dana C., Talia Harris, Keren Sasson, et al.. (2023). Deuterium imaging of the Warburg effect at sub‐millimolar concentrations by joint processing of the kinetic and spectral dimensions. NMR in Biomedicine. 36(11). e4995–e4995. 10 indexed citations

Rousso-Noori, Liat, et al.. (2021). Exploring the longitudinal glioma microenvironment landscape uncovers reprogrammed pro-tumorigenic neutrophils in the bone marrow. Cell Reports. 36(5). 109480–109480. 42 indexed citations

Haedicke, Katja, Lilach Agemy, Murad Omar, et al.. (2020). High-resolution optoacoustic imaging of tissue responses to vascular-targeted therapies. Nature Biomedical Engineering. 4(3). 286–297. 96 indexed citations

Agemy, Lilach, et al.. (2020). Exploring the Longitudinal Glioma Microenvironment Landscape Uncovers Reprogrammed Pro-Tumorigenic Neutrophils in the Bone Marrow. SSRN Electronic Journal. 5 indexed citations

Lui, Sylvia, Kate Widdows, Venkata Ramana Kotamraju, et al.. (2016). Tumor-homing peptides as tools for targeted delivery of payloads to the placenta. Science Advances. 2(5). e1600349–e1600349. 135 indexed citations

Agemy, Lilach, Itai Kela, Tova Waks, et al.. (2013). Gene Expression Profiles Predict Sensitivity of Prostate Cancer to Radiotherapy. Journal of Cancer Therapy. 4(4). 11–26. 3 indexed citations

10.

Agemy, Lilach, Venkata Ramana Kotamraju, Dinorah Friedmann‐Morvinski, et al.. (2013). Proapoptotic Peptide-Mediated Cancer Therapy Targeted to Cell Surface p32. Molecular Therapy. 21(12). 2195–2204. 75 indexed citations

11.

Roth, Lise, Kazuki N. Sugahara, Lilach Agemy, et al.. (2012). De Novo Design of a Tumor-Penetrating Peptide. Cancer Research. 73(2). 804–812. 142 indexed citations

12.

Zanuy, David, Francisco J. Sayago, Guillem Revilla‐López, et al.. (2012). Engineering strategy to improve peptide analogs: from structure-based computational design to tumor homing. Journal of Computer-Aided Molecular Design. 27(1). 31–43. 14 indexed citations

13.

Agemy, Lilach, Dinorah Friedmann‐Morvinski, Venkata Ramana Kotamraju, et al.. (2011). Targeted nanoparticle enhanced proapoptotic peptide as potential therapy for glioblastoma. Proceedings of the National Academy of Sciences. 108(42). 17450–17455. 300 indexed citations

14.

Hamzah, Juliana, Venkata Ramana Kotamraju, Jai Woong Seo, et al.. (2011). Specific penetration and accumulation of a homing peptide within atherosclerotic plaques of apolipoprotein E-deficient mice. Proceedings of the National Academy of Sciences. 108(17). 7154–7159. 93 indexed citations

15.

Girard, Olivier M., Jiang Du, Lilach Agemy, et al.. (2011). Optimization of iron oxide nanoparticle detection using ultrashort echo time pulse sequences: Comparison of T₁, T₂*, and synergistic T₁ − T₂* contrast mechanisms. Magnetic Resonance in Medicine. 65(6). 1649–1660. 46 indexed citations

16.

Roth, Lise, Lilach Agemy, Venkata Ramana Kotamraju, et al.. (2011). Transtumoral targeting enabled by a novel neuropilin-binding peptide. Oncogene. 31(33). 3754–3763. 201 indexed citations

17.

Sugahara, Kazuki N., Tambet Teesalu, Priya Karmali, et al.. (2010). Coadministration of a Tumor-Penetrating Peptide Enhances the Efficacy of Cancer Drugs. Science. 328(5981). 1031–1035. 876 indexed citations breakdown →

18.

Sugahara, Kazuki N., Tambet Teesalu, Priya Karmali, et al.. (2009). Tissue-Penetrating Delivery of Compounds and Nanoparticles into Tumors. Cancer Cell. 16(6). 510–520. 925 indexed citations breakdown →

19.

Agemy, Lilach, Alon Harmelin, Tova Waks, et al.. (2008). Irradiation enhances the metastatic potential of prostatic small cell carcinoma xenografts. The Prostate. 68(5). 530–539. 15 indexed citations

20.

Sharoni, Yoav, Michael Danilenko, Shlomo Walfisch, et al.. (2002). Role of gene regulation in the anticancer activity of carotenoids. Pure and Applied Chemistry. 74(8). 1469–1477. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact